Australia's Echo IQ surges on inking licensing deal with Advara HeartCare
02/07/2026 02:48
BUZZ-Australia's Echo IQ surges on inking licensing deal with Advara HeartCare ** Shares of Echo IQ EIQ.AX rise as much as 8.3% to A$1.755, their highest level since June 25
** AI medtech co executes definitive exclusive data licensing agreement with Advara HeartCare, the country's largest private cardiovascular diagnostics provider
** The agreement provides the company with exclusive access to Advara's cardiovascular imaging datasets
** YTD, stock up 569.3%
(Reporting by Nichiket Sunil in Bengaluru)
Recent news on EchoIQ
See all newsAustralia's EchoIQ gains most in nearly 3 months after FDA update
Brief: EchoIQ Says FDA Raises No Concerns About Echosolv HF Technology Or Core Functionality
Australia's EchoIQ heads for worst week in seven years after US FDA setback
Australia's Echo IQ logs worst day in seven years after FDA setback
Brief: EchoIQ Requests Trading Halt